GlobalData on MSN6d
Trevi Therapeutics enrols all subjects in trial of Haduvio for chronic cough in IPFTrevi Therapeutics has finished enrolling subjects in a trial of investigational Haduvio for treating chronic cough in IPF ...
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy ...
About Trevi Therapeutics, Inc. Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine extended-release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback